Literature DB >> 25000321

Everyday cognition in prodromal Huntington disease.

Janet K Williams1, Ji-In Kim2, Nancy Downing1, Sarah Farias3, Deborah L Harrington4, Jeffrey D Long5, James A Mills5, Jane S Paulsen5.   

Abstract

OBJECTIVE: Assessment of daily functions affected by cognitive loss in prodromal Huntington's disease (HD) is necessary in practice and clinical trials. We evaluated baseline and longitudinal sensitivity of the Everyday Cognition (ECog) scales in prodromal HD and compared self- and companion-ratings.
METHOD: Everyday cognition was self-assessed by 850 participants with prodromal HD and 768 companions. We examined internal structure using confirmatory factor analysis (CFA) on baseline data. For longitudinal analysis, we stratified participants into Low, Medium, and High disease progression groups. We examined ECog scores for group differences and participant-and-companion differences using linear mixed effects regression (LMER). Comparison with the Total Functional Capacity (TFC) scale was made.
RESULTS: CFA revealed good fit of a 5-factor model having a global factor (total score), and subfactors (subscales) of memory, language, visuospatial perception, and executive function. At study entry, participants and companions in the Medium and High groups reported significantly worsened everyday cognition as well as significant functional decline over time. Losses became more pronounced and participant and companion ratings diverged as individuals progressed. TFC showed significant functional loss over time in the High group but not in the Medium group.
CONCLUSIONS: Disease progression is associated with reduced self- and companion-reported everyday cognition in prodromal HD participants who are less than 13 years to estimated motor onset. Our findings suggest companion ratings are more sensitive than participants' for detecting longitudinal change in daily cognitive function. ECog appears more sensitive to specific functional changes in the prodrome of HD than the TFC. PsycINFO Database Record (c) 2015 APA, all rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25000321      PMCID: PMC4286521          DOI: 10.1037/neu0000102

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  60 in total

1.  Huntington disease: clinical care and evaluation.

Authors:  I Shoulson; S Fahn
Journal:  Neurology       Date:  1979-01       Impact factor: 9.910

2.  Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Authors:  Sarah J Tabrizi; Ralf Reilmann; Raymund A C Roos; Alexandra Durr; Blair Leavitt; Gail Owen; Rebecca Jones; Hans Johnson; David Craufurd; Stephen L Hicks; Christopher Kennard; Bernhard Landwehrmeyer; Julie C Stout; Beth Borowsky; Rachael I Scahill; Chris Frost; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2011-12-02       Impact factor: 44.182

3.  Concordance of self- and proxy-rated worry and anxiety symptoms in older adults with dementia.

Authors:  Andrea Bradford; Gretchen A Brenes; Roberta A Robinson; Nancy Wilson; A Lynn Snow; Mark E Kunik; Jessica Calleo; Nancy J Petersen; Melinda A Stanley; Amber B Amspoker
Journal:  J Anxiety Disord       Date:  2012-11-23

4.  The measurement of everyday cognition: development and validation of a short form of the Everyday Cognition scales.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Danielle J Harvey; Amanda Simmons; Bruce R Reed; Charles Decarli
Journal:  Alzheimers Dement       Date:  2011-11       Impact factor: 21.566

5.  Cognitive impairment in medical inpatients. I: Screening for dementia--is history better than mental state?

Authors:  D M Harwood; T Hope; R Jacoby
Journal:  Age Ageing       Date:  1997-01       Impact factor: 10.668

6.  Discriminative and predictive power of an informant report in mild cognitive impairment.

Authors:  V Isella; L Villa; A Russo; R Regazzoni; C Ferrarese; I M Appollonio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

7.  The cognitive decline scale of the psychogeriatric assessment scales (PAS): longitudinal data on its validity.

Authors:  A F Jorm; H Christensen; P A Jacomb; A E Korten; A J Mackinnon
Journal:  Int J Geriatr Psychiatry       Date:  2001-03       Impact factor: 3.485

8.  Unawareness of motor phenoconversion in Huntington disease.

Authors:  Elizabeth A McCusker; David G Gunn; Eric A Epping; Clement T Loy; Kylie Radford; Jane Griffith; James A Mills; Jeffrey D Long; Jane S Paulsen
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

9.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

10.  WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease.

Authors:  Nancy R Downing; Ji-In Kim; Janet K Williams; Jeffrey D Long; James A Mills; Jane S Paulsen
Journal:  Eur J Hum Genet       Date:  2013-12-11       Impact factor: 4.246

View more
  10 in total

1.  Phenotype Characterization of HD Intermediate Alleles in PREDICT-HD.

Authors:  Nancy R Downing; Spencer Lourens; Isabella De Soriano; Jeffrey D Long; Jane S Paulsen
Journal:  J Huntingtons Dis       Date:  2016-12-15

2.  Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?

Authors:  N E Carlozzi; S Schilling; A L Kratz; J S Paulsen; S Frank; J C Stout
Journal:  Qual Life Res       Date:  2018-06-16       Impact factor: 4.147

Review 3.  Beyond muscles: The untapped potential of creatine.

Authors:  Lisa A Riesberg; Stephanie A Weed; Thomas L McDonald; Joan M Eckerson; Kristen M Drescher
Journal:  Int Immunopharmacol       Date:  2016-01-08       Impact factor: 4.932

4.  The Everyday Cognition Scale in Parkinson's disease.

Authors:  Rachel A Cooper; Jared Benge; Crystal Lantrip; Michael J Soileau
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

5.  Psychometric properties and responsiveness of Neuro-QoL Cognitive Function in persons with Huntington disease (HD).

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Jane S Paulsen; Nancy R Downing; Rebecca Ready; Joel S Perlmutter; David Cella; Kelvin L Chou; Michael K McCormack; Stacey Barton; Jin-Shei Lai
Journal:  Qual Life Res       Date:  2019-12-18       Impact factor: 4.147

6.  Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.

Authors:  Maria B Misiura; Spencer Lourens; Vince D Calhoun; Jeffrey Long; Jeremy Bockholt; Hans Johnson; Ying Zhang; Jane S Paulsen; Jessica A Turner; Jingyu Liu; Betul Kara; Elizabeth Fall
Journal:  J Int Neuropsychol Soc       Date:  2017-02       Impact factor: 2.892

Review 7.  Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells.

Authors:  Kalina Wiatr; Wojciech J Szlachcic; Marta Trzeciak; Marek Figlerowicz; Maciej Figiel
Journal:  Mol Neurobiol       Date:  2017-05-11       Impact factor: 5.590

8.  Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms.

Authors:  Maria Masnata; Giacomo Sciacca; Alexander Maxan; Luc Bousset; Hélèna L Denis; Florian Lauruol; Linda David; Martine Saint-Pierre; Jeffrey H Kordower; Ronald Melki; Melanie Alpaugh; Francesca Cicchetti
Journal:  Acta Neuropathol       Date:  2019-02-20       Impact factor: 17.088

9.  Exploring the Reliability and Validity of the Huntington's Disease Quality of Life Battery for Carers (HDQoL-C) within A Polish Population.

Authors:  Agnieszka Bartoszek; Aimee Aubeeluck; Edward Stupple; Adrian Bartoszek; Katarzyna Kocka; Barbara Ślusarska
Journal:  Int J Environ Res Public Health       Date:  2019-06-30       Impact factor: 3.390

10.  Therapeutic Use of Music, Dance, and Rhythmic Auditory Cueing for Patients with Huntington's Disease: A Systematic Review.

Authors:  Anna E Schwartz; Marleen R van Walsem; Are Brean; Jan C Frich
Journal:  J Huntingtons Dis       Date:  2019
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.